Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease
出版年份 2018 全文链接
标题
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson’s disease
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 25, Pages E5815-E5823
出版商
Proceedings of the National Academy of Sciences
发表日期
2018-06-20
DOI
10.1073/pnas.1802179115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neuropathology of Parkinson disease
- (2018) Dennis W. Dickson PARKINSONISM & RELATED DISORDERS
- Updates on immunity and inflammation in Parkinson disease pathology
- (2017) Neeraj Joshi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress
- (2017) Hui-Ju Huang et al. MOLECULAR NEUROBIOLOGY
- Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins
- (2017) C. Warren Olanow et al. MOVEMENT DISORDERS
- New drugs for Parkinson's disease: The regulatory and clinical development pathways in the United States
- (2017) Karl Kieburtz et al. MOVEMENT DISORDERS
- Non-motor features of Parkinson disease
- (2017) Anthony H.V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
- (2017) Karen M. Wagner et al. PHARMACOLOGY & THERAPEUTICS
- Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors
- (2017) Bora Inceoglu et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts
- (2017) Eleonora Napoli et al. STEM CELLS
- Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress
- (2017) Rajib Paul et al. PLoS One
- ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway
- (2016) Gabriela Mercado et al. BRAIN RESEARCH
- Soluble epoxide hydrolase: a new therapeutic target for depression
- (2016) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Molecular changes in the postmortem parkinsonian brain
- (2016) Damien Toulorge et al. JOURNAL OF NEUROCHEMISTRY
- The epidemiology of Parkinson's disease: risk factors and prevention
- (2016) Alberto Ascherio et al. LANCET NEUROLOGY
- Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders
- (2016) Navya Lakkappa et al. MEDICAL HYPOTHESES
- Fatty acids and their therapeutic potential in neurological disorders
- (2016) Enie Lei et al. NEUROCHEMISTRY INTERNATIONAL
- Detecting depression in Parkinson disease
- (2016) Zahra Goodarzi et al. NEUROLOGY
- Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress
- (2016) Qian Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
- (2015) Benjamin Dehay et al. LANCET NEUROLOGY
- Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain
- (2015) Bora Inceoglu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
- (2015) Annika I. Ostermann et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice
- (2015) Todd R. Harris et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism
- (2014) Xiaocui Qin et al. MOLECULAR NEUROBIOLOGY
- Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides
- (2014) Cristina López-Vicario et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling
- (2014) Karen Wagner et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer
- (2014) Weicang Wang et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Soluble epoxide hydrolase: Gene structure, expression and deletion
- (2013) Todd R. Harris et al. GENE
- Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue
- (2013) Ahmed Bettaieb et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-inflammatory Effects of ω-3 Polyunsaturated Fatty Acids and Soluble Epoxide Hydrolase Inhibitors in Angiotensin-II–Dependent Hypertension
- (2013) Arzu Ulu et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Metabolic Signatures of Extreme Longevity in Northern Italian Centenarians Reveal a Complex Remodeling of Lipids, Amino Acids, and Gut Microbiota Metabolism
- (2013) Sebastiano Collino et al. PLoS One
- Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
- (2012) Christophe Morisseau et al. Annual Review of Pharmacology and Toxicology
- Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
- (2012) Yoichi Imaizumi et al. Molecular Brain
- Impact of omega-3 fatty acids in Parkinson's disease
- (2011) Mélanie Bousquet et al. AGEING RESEARCH REVIEWS
- Neuroinflammation in Parkinson's disease
- (2011) Etienne C. Hirsch et al. PARKINSONISM & RELATED DISORDERS
- 1-Aryl-3-(1-acylpiperidin-4-yl)urea Inhibitors of Human and Murine Soluble Epoxide Hydrolase: Structure−Activity Relationships, Pharmacokinetics, and Reduction of Inflammatory Pain
- (2010) Tristan E. Rose et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
- (2009) Jun-Yan Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
- (2009) John D. Imig et al. NATURE REVIEWS DRUG DISCOVERY
- Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy
- (2009) Sho TAKAHASHI et al. Psychogeriatrics
- Mitochondria in the aetiology and pathogenesis of Parkinson's disease
- (2008) Anthony HV Schapira LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search